It has a fast-tempo growth and low risk. Plus, Turkey has a younger population.

We have very aggressive expansion plans for acquisitions in Russia and abroad.

This is a major operation in a high-risk population.

Statistically then, the risk is approximately 1 in 1,000, which is substantially higher than in the normal population. We're also careful to say we do not know what the risk is for individuals with long-term use of the drug.

The risk to the general population is very low.

Immigration is one of the leading contributors to population growth.